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Abstract 
Breast cancer is the most common cancer in 
women worldwide. The two main types of invasive 
breast cancer are invasive ductal and invasive 
lobular carcinoma. The most common sites of 
breast cancer metastasis encountered are liver, lung, 
bone and brain. Metastasis of primary lobular breast 
carcinoma to gastrointestinal (GI) tract is a well-
known yet rare occurrence with reported incidence 
ranging from 2% to 18%. We report four such cases 
of invasive lobular breast carcinoma metastasizing 
to the GI tract, and review the literature.  
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Introduction 
Breast cancer is the most common cancer in 
women worldwide. According to the Global Health 
Estimates, World Health Organization 2013, breast 
cancer was responsible for over 508 000 deaths in 
2011. Women in Western Europe saw greater 
incidence of breast cancer, 89.7 per 100,000, when 
compared to women in Eastern Africa where the 
incidence of breast cancer was 19.3 per 100,000.1  
The two main types of invasive breast cancer 
are invasive ductal carcinoma comprising 80% of 
invasive breast cancers, and invasive lobular 
carcinoma accounting for about 10%.2 Most 
commonly breast cancer is known to metastasize to 
the liver, lung, bone and brain. In addition to these 
common sites, the propensity of invasive lobular 
carcinoma to metastasize to extra hepatic 
gastrointestinal (GI) sites, peritoneum, and adnexae 
has been well reported in the literature.3-6,11 Despite 
this, metastasis of primary lobular breast carcinoma 
to GI tract is a rare occurrence, with reported 
incidence ranging from 0.7% to 18%. The stomach 
is the most commonly affected organ and metastasis 
here most often presents as linitis plastica.3,4,8,10,12,19 
The finding of GI tract metastasis as the first 
presentation of breast carcinoma is particularly 
uncommon, but does occur.3 We report four cases 
of primary breast carcinoma metastasizing to GI 
tract, with one of the patients being diagnosed with 
primary breast cancer and GI metastasis 
synchronously. Our patients experienced a wide 
range of gastrointestinal symptoms varying from 
vague discomfort and loss of appetite to severe 
abdominal pain, nausea and vomiting.  
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Case Presentations 
 
Case presentation 1 
A 67-year-old female presented to our 
outpatient clinic in view of severe weight loss and 
loss of appetite.  No other associated symptoms 
were reported. On physical examination she was 
found to have a palpable, non-tender epigastric 
mass, accompanied by left breast deformity with an 
underlying breast lump. When questioned further, it 
transpired that the left breast mass had been present 
for 20 years, during which she never sought medical 
attention. CT study revealed small ill defined 
hypodense lesions in the liver due to possible 
metastasis, thickening of the wall of the stomach a 
17 mm round lesion between stomach, splenic vein 
and spleen, and rectal wall thickening accompanied 
by pelvic ascites. Also of note was the finding of 
collapsed of sixth thoracic vertebra and irregular 
bone texture of thoracic vertebrae 5 and 11 and the 
second lumbar vertebra.    
OGD confirmed the CT results noting a thick, 
rigid stomach wall suggestive of linitis plastica 
extending from the oesophaghogastric junction 
(OGJ) to the pylorus. Biopsy of the breast mass 
revealed invasive lobular carcinoma grade II, 
estrogen receptor (ER) and progesterone receptor 
(PR) positive and Her 2 and E-cadherin negative 
Endoscopic biopsy demonstrated metastatic 
mammary lobular carcinoma expressing cytokeratin 
7 (CK7) and ER receptors, with cytokeratin 20 
(CK20), the homeobox intestinal differentiation 
factor CDX2, and E-Cadherin negative (Figure 1). 
The rectal thickening found on the CT scan was 
suggestive of metastasis to the rectum, however this 
was not confirmed by biopsy due to patient’s 
unwillingness to undergo the procedure.  
The patient was referred to oncology and 
chemotherapy was initiated.  
 
 
 
Figure. 1: Stomach biopsy specimen stained with H&E, showing extensive infiltration of the lamina propria by 
malignant decohesive epithelial cells, consistent with metastatic mammary lobular carcinoma. 
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Case Presentation 2  
A 56 year old female presented to the 
outpatient clinic with a five-day history of 
constipation, colicky abdominal pain, nausea and 
vomiting. Nine years prior to this presentation the 
patient had undergone a wide local excision and 
axillary clearance for a left breast lump. 
Postoperative histology showed invasive lobular 
carcinoma, grade II, ER positive with no metastasis 
to axillary lymph nodes. She was subsequently 
treated with radiotherapy to the left breast and five-
year course of Tamoxifen. Seven years later patient 
was diagnosed with regional metastases and treated 
with radiotherapy to cervical, pectoral and internal 
mammary regions followed by a course of 
chemotherapy. 
CT scan of abdomen and pelvis showed 
multiple dilated ileal loops with a transition point in 
the distal ileum and a moderate amount of ascites. 
At laparotomy small bowel stricture was identified 
and resected together with a peritoneal nodule. 
Histological sections from small intestine 
confirmed diffuse infiltration by a grade III invasive 
lobular carcinoma (Figures 2a and 2b), which 
involved the whole thickness of the intestinal wall 
with widespread vascular and perineural invasion 
and lymph nod metastasis. The peritoneal nodules 
examined revealed the presence of metastatic 
lobular carcinoma. The tumor was found to be ER, 
PR, Her2 and E-cadherin negative. The patient 
underwent chemotherapy treatment. 
 
 
 
Figures 2a and 2b: Sections from the small intestine stained with H&E, showing diffuse infiltration by grade 
III invasive lobular carcinoma involving the whole thickness of the intestinal wall. 
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Case presentation 3 
An 88-year-old female presented to the 
outpatient clinic in view of large (8x5x3.5cm), firm, 
and mobile mass in the right axilla associated with 
right nipple retraction. Right axillary excisional 
biopsy was preformed, which showed ER positive, 
infiltrating metastatic adenocarcinoma from a 
primary breast carcinoma. The patient underwent 
radiotherapy to the right breast and axilla, and 
hormonal treatment of Tamoxifen was initiated with 
good response. Follow up radiological studies 
revealed no spread and no distant metastases. 
Eleven years later the patient presented to the 
Emergency Department with persistent nausea and 
vomiting. Upper GI follow through showed an 
obstructing stricture in the distal duodenum and 
duodeno-jejunal flexure. Exploratory laparotomy 
showed a tumour obstructing the small bowel at the 
duodeno-jejunal flexure, para-aortic 
lymphadenopahy and deposits on anti-mesenteric 
border of jejunum. Biopsy of the stricture was 
taken, and gastrojejunostomy fashioned. Histology 
revealed metastatic lobular breast carcinoma to GI 
tract (Figure 3).  
 
 
Figure 3: Histology specimen from the duodeno-jejunal flexure stained with H&E, showing metastatic 
adenocarcinoma from breast primary. Tumour cells can be seen in the bowel mucosa surrounded by 
inflammatory cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case Presentation 4 
A 52 year old female with a history of right 
mastectomy with axillary clearance for invasive 
lobular cancer metastasizing to 6 out of 29 axillary 
lymph nodes 6 years prior, presented with epigastric 
discomfort and 20 kg weight loss in 3 months. In 
view of her history and raised Ca 125, a CT scan of 
thorax, abdomen and pelvis were preformed which 
demonstrated an irregularity at the gastroesophageal 
junction and edema of the wall of the stomach with 
free pelvic fluid. Multiple osteolytic bone lesions 
were also noted in the spine and pelvis. 
Oesophagogastroduodenoscopy (OGD) and 
endoscopic gastric cardia biopsies were carried out. 
The histology confirmed metastatic lobular breast 
carcinoma ER, HER2, cytokeratin 7 (CK7) and 
gross cystic disease fluid protein 15 (GCDFP-15) 
positive, and PR, cytokeratin 20 (CK20), 
lymphocyte common antigen CD45, and E-cadherin 
negative (Figure 4). Cytology of free peritoneal 
fluid during the staging laparoscopy demonstrated 
adenocarcinoma. The patient was referred to 
oncology for further treatment.  
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Figure 4: Gastric cardia biopsies. Neoplastic cells infiltrating lamina propria, arranged in trabecules and 
single-cell lines as shown.  Atypical epithelial cells are ER and HER2 positive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The expected site of breast cancer metastasis 
commonly includes lung, liver, bone and brain. 
However, invasive breast carcinoma of lobular 
pathology, in addition to metastasizing to the listed 
sites, also has a propensity to metastasize to unusual 
areas such as GI tract, peritoneum and adnexa.6 
This difference in metastatic pattern of lobular and 
ductal carcinoma was demonstrated by Borst et al. 
who analyzed the rates of metastasis of invasive 
lobular vs. invasive ductal carcinoma and were able 
to show that rate of metastasis to the gastrointestinal 
tract (4.5% vs 0.2%), gynecologic organs (4.5% vs 
0.8%), peritoneum-retroperitoneum (3.1% vs 0.6%), 
adrenal glands (0.6% vs 0%), bone-marrow (21.2% 
vs 14.4%), and lung-pleura (2.5% vs 10.2%) were 
significantly different (p<0.05).21 The time interval 
from diagnosis of primary breast cancer to 
metastasis to GI is up to 30 years.14  
The reported incidence of invasive lobular 
carcinoma metastasis to GI tract ranges from 0.7-
18%.8,12 The stomach seems to be the most 
common site of metastasis. During the year 2000, 
Taal et al. retrospectively evaluated 51 patients with 
metastatic gastric carcinoma and found that 83% of 
patients with gastric involvement had lobular breast 
cancer as a primary histological subtype.16 Similar 
findings were observed by Almubarak et al. who 
completed a single institution retrospective study of 
35 patients with metastatic breast carcinoma to the 
stomach and found that 97% of the gastric 
metastasis from a breast cancer was derived from 
invasive lobular carcinoma. In lobular breast 
carcinoma, gastric metastasis most often presents as 
linitis plastica, while metastatic ductal breast 
carcinoma exhibits a nodular pattern.4,8,10   
What gives metastatic linitis plastica its 
appearance is a diffuse infiltration of gastric wall by 
poorly differentiated tumor cells, resulting in 
reactive fibrosis.9 As in our case, metastatic linitis 
plastica is usually diagnosed by endoscopy and 
endoscopic biopsy, although CT plays an important 
role in diagnosing metastases beyond the stomach. 
Endoscopic findings may present in 3 different 
patterns: localized lesions (18%), diffuse infiltration 
(57%), and external compression at the cardia or 
pylorus (25%).16 When taking a biopsy during 
endoscopic procedures it is important to take deep 
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biopsies due to the observation that  diffuse 
infiltration is predominantly seen within the 
submucosa and muscularis propria.9  
The differentiation between the primary breast 
cancer metastasis to GI tract and primary gastric 
cancer is of upmost importance, as the treatment 
options will differ greatly. It may be difficult to 
distinguish between primary and metastatic lesions 
using only histology. In some cases metastasis of 
lobular breast carcinoma mimics primary gastric 
adenocarcinoma by producing signet ring 
morphology, making it almost indistinguishable 
from primary gastric linitis plastica. Therefore, 
immunohistochemistry can be of great help in 
determining the accurate diagnosis.18  
Symptoms elicited by metastasis to GI tract 
are variable ranging from vague abdominal 
discomfort to acute GI symptoms. Symptoms 
encountered most often are weight loss, early 
satiety, nausea, vomiting and abdominal pain, 
however, incidental finding of metastases in 
asymptomatic patients is also common.7,11 Taal et 
al. in review of 51 patients found that most 
common presentation was anorexia (71%), followed 
by epigastric pain (53%), and vomiting (41%).16 
Metastasis to the GI tract from invasive 
carcinoma of the breast represents evidence of 
systemic disease and as such it is primarily treated 
with chemotherapy, hormonal therapy or 
combination of the two. A partial remission with a 
clear palliative effect was demonstrated in only 
46% of patients receiving systemic therapy with no 
obvious difference in response rates between 
hormonal treatment and chemotherapy. Surgical 
intervention is reserved for complications such as 
bleeding or obstruction.15-16,18 The choice of 
treatment depends on the presenting symptoms, age, 
general condition, receptor status, and previous 
systemic treatments.20 Advanced age at diagnosis 
and gastric metastases has a negative effect on 
survival, whereas treatment with systemic 
chemotherapy or Tamoxifen carries a positive effect 
on survival.19 McLemore et al reported that surgical 
intervention did not have a significant effect on 
survival (28 vs. 26 months).19 Some survival benefit 
was seen in a select group of patients with 
metastasis only to the GI tract that underwent 
palliative surgical resection. Surgical intervention 
should be reserved for palliation, or may be a 
reasonable choice in cases of solitary resectable GI 
tract metastases. Appropriate systemic treatment for 
metastatic breast carcinoma is the preferred 
treatment. 
The reported median survival of patients 
undergoing systemic treatment for metastatic breast 
cancer to the stomach and gastrointestinal tract 
varied between 10 and 28 months.17,29,22  
 
Conclusion 
When a patient with a history of breast cancer 
presents with gastrointestinal symptoms, or an 
apparent primary gastric cancer is diagnosed, a high 
index of suspicion for a potential breast cancer 
metastasis has to be maintained. The differentiation 
between breast cancer metastasis from primary 
gastric cancer is of upmost importance, as the 
treatment options of the two differ greatly. 
Furthermore, increased awareness of the possibility 
of breast cancer metastasis should be observed in 
females without history of breast cancer who are 
diagnosed with diffuse-type gastric cancer or 
gastrointestinal carcinoma of unknown origin.  
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